HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.

Abstract
Recent investigations have shown that malignant transformation may down-regulate the expression of class I HLA molecules, beta2-microglobulin (beta2m) and members of the antigen-processing machinery. In the present study, we HLA-genotyped and identified at a biochemical level the three (HLA-A25, -B8, -Cw7) class I alleles expressed by the previously described [D'Urso CM et al (1992) J Clin Invest 87: 284-292] beta2m-defective human melanoma FO-1 cell line and tested their ability to interact with calnexin, calreticulin and the TAP (transporter associated with antigen processing) complex. All these alleles were found to bind calnexin, but not calreticulin or the poorly expressed TAP complex, both in parental and beta2m-transfected FO-1 cells, demonstrating a complex defect of class I expression in FO-1 cells. In these conditions, Cw7 heavy chains interacted with calnexin more strongly than A25 and B8, and preferentially accumulated in the endoplasmic reticulum, in both a calnexin-associated and a calnexin-free form. In addition, they could be transported to the cell surface at low levels even in the absence of beta2m, without undergoing terminal glycosylation. These results establish a parallel between HLA-C and the murine Db and Ld molecules which have been found to be surface expressed and functional in beta2m-defective cells. They also demonstrate distinctive features of HLA-C molecules. We propose that the accumulation of several assembly intermediates of HLA-C might favour the binding of peptide antigens not readily bound by HLA-A and -B molecules in neoplastic cells with suboptimal class I expression.
AuthorsA Martayan, R Fraioli, E Giorda, A Setini, G Ciccarelli, L Delfino, G B Ferrara, P Giacomini
JournalBritish journal of cancer (Br J Cancer) Vol. 80 Issue 5-6 Pg. 639-49 (May 1999) ISSN: 0007-0920 [Print] England
PMID10360639 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium-Binding Proteins
  • Calreticulin
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-C Antigens
  • Histocompatibility Antigens Class I
  • Ribonucleoproteins
  • beta 2-Microglobulin
  • Calnexin
Topics
  • Alleles
  • Animals
  • Calcium-Binding Proteins (metabolism)
  • Calnexin
  • Calreticulin
  • Flow Cytometry
  • Genotype
  • HLA-A Antigens (biosynthesis, genetics)
  • HLA-B Antigens (biosynthesis, genetics)
  • HLA-C Antigens (biosynthesis, genetics)
  • Histocompatibility Antigens Class I (biosynthesis, genetics)
  • Humans
  • Melanoma (genetics, metabolism)
  • Mice
  • Protein Conformation
  • Ribonucleoproteins (metabolism)
  • Transfection
  • Tumor Cells, Cultured
  • beta 2-Microglobulin (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: